Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis

Neurology

Volumn 44, Issue 4, 1994, Pages 635-641

  Filippi, M ^a   Horsfield, M A ^a   Morrissey, S P ^a   MacManus, D G ^a   Rudge, P ^a   Mc Donald, W I ^a   Miller, David H ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN DISEASE; BRAIN STEM INJURY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE DISEASE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SPINAL CORD DISEASE; SYNDROME;

ADOLESCENT; ADULT; BRAIN; CHILD; DISABILITY EVALUATION; FOLLOW-UP STUDIES; FORECASTING; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 0028359265     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.44.4.635     Document Type: Article

References (54)

1. Shibasaki H, Mc Donald WI, Kuroiwa Y. Racial modification of the clinical picture of multiple sclerosis; comparison between British and Japanese patients. J Neurol Sci 1981;49:253-271.
2. Ebers GC. Optic neuritis and multiple sclerosis. Arch Neurol 1985;42:702-704.
3. Francis DA, Compston DAS, Batchelor JR, McDonald WI. A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up. J Neurol Neurosurg Psychiatry 1987;50:758-765.
4. Rizzo JF III, Lessell S. Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study. Neurology 1988;38:185-190.
5. Perkin GD, Rose FC. Optic neuritis and its differential diagnosis. Oxford, UK: Oxford University Press, 1979.
6. Morrissey SP, Miller DH, Kendall BE, et al. Prognostic significance of brain MRI at presentation with a clinically isolated syndrome suggestive of MS a five-year follow-up study. Brain 1993;116:135-146.
7. Miller DH, Ormerod IEC, Rudge P, et al. The early risk of multiple sclerosis following acute syndromes of the brainstem and spinal cord. Ann Neurol 1989;26:635-639.
8. Ford B, Tampieri D, Francis G. Long-term follow-up of acute partial transverse myelopathy. Neurology 1992; 42:250-252.
9. Lipton HL, Teasdall RD. Acute transverse myelopathy in adults. Arch Neurol 1973;28:252-257.
10. Ormerod IEC, McDonald WI, du Boulay EPGH, et al. Disseminated lesions at presentation with optic neuritis. J Neurol Neurosurg Psychiatry 1986;49:124-127.
11. Ormerod IEC, Bronstein AM, Rudge P, et al. Magnetic resonance imaging in clinically isolated lesions of the brainstem. J Neurol Neurosurg Psychiatry 1986;49:737-743.
12. Jacobs L, Kinkel PR, Kinkel WR. Silent brain lesions in patients with isolated optic neuritis. A clinical and nuclear magnetic resonance study. Arch Neurol 1986;43:452-455.
13. Miller DH, McDonald WI, Blumhardt LD, et al. Magnetic resonance imaging in isolated non-compressive spinal cord syndromes. Ann Neurol 1987;22:714-723.
14. Paty DW, Oger JJF, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1988;38:180-185.
15. Miller DH, Ormerod IEC, McDonald WI, et al. The early risk of multiple sclerosis after optic neuritis. J Neurol Neurosurg Psychiatry 1988;51:1569-1571.
16. Frederiksen JL, Larsson HBW, Olesen J, Stigsby B. MRI, VEP, SEP and biothesiometry suggest monosymptomatic acute optic neuritis to be a first manifestation of multiple sclerosis. Acta Neurol Scand 1991;83:343-350.
17. Lee KH, Hashimoto SA, Hooge JP, et al. Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1991;41:657-660.
18. Martinelli V, Comi GC, Filippi M, et al. Paraclinical tests in acute-onset optic neuritis: basal data and results of a short follow-up. Acta Neurol Scand 1991;84:231-236.
19. Rao SM, Leo GJ, Haughton VM, St. Aubin-Faubert P, Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989;39:161-166.
20. Wicks DAG, Tofts PS, Miller DH, et al. Volume measurements of multiple sclerosis lesions with magnetic resonance images: a preliminary study. Neuroradiology 1992;34:475-479.
21. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
22. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231.
23. Wicks DAG, Barker GJ, Tofts PS. Correction of intensity non-uniformity in MR images of any orientation. Magn Reson Imaging 1992;11:183-196.
24. Jacobs L, Munschauer FE, Kaba SE. Clinical and magnetic resonance imaging in optic neuritis. Neurology 1991;41:15-19.
25. Koopmans RA, Li DKB, Grochowski E, et al. Benign versus chronic progressive multiple sclerosis: magnetic resonance imaging features. Ann Neurol 1989;25:74-81.
26. Brant-Zawadski M, Feng G, Van Dicke C, et al. MR imaging of the ageing brain: patchy white matter lesions and dementia. AJNR Am J Neuroradiol 1985;6:675-682.
27. Gerard G, Weisberg LA. MRI periventricular lesions in adults. Neurology 1986;36:998-1001.
28. Fazekas F. Magnetic resonance signal abnormalities in asymptomatic individuals: their incidence and functional correlates. Eur Neurol 1989;29:164-168.
29. Ferbert A, Busse D, Thron A. Microinfarction in classic migraine? A study with magnetic resonance imaging findings. Stroke 1991;22:1010-1014.
30. Cohen MM, Lessell S, Wolf PA. A prospective study of the risk of developing multiple sclerosis in uncomplicated optic neuritis. Neurology 1979;29:208-213.
31. Landy PJ. A prospective study of the risk of developing multiple sclerosis in optic neuritis in a tropical and subtropical area. J Neurol Neurosurg Psychiatry 1983;46:659-661.
32. Fazekas F, Offenbacher H, Fuchs F, et al. Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology 1988;38:1822-1825.
33. Atlas SW, Grossman RI, Goldberg HI, et al. MR diagnosis of acute disseminated encephalomyelitis. J Comput Assist Tomogr 1986;8:381-384.
34. Dunn V, Bale JF, Zimmerman RD, et al. MRI in children with post infectious disseminated encephalomyelitis. Magn Reson Imaging 1986;4:25-32.
35. Kesselring J, Miller DH, Robb SA, et al. Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis. Brain 1990;113:291-302.
36. Allen IV, Glover G, Anderson R. Abnormalities in the macroscopically normal white matter in cases of mild or spinal multiple sclerosis. Acta Neuropathol (Berl) 1981;suppl VIL 176-178.
37. Ikita F, Zimmerman HM. Distribution of plaques in seventy cases of multiple sclerosis in the United States. Neurology 1976;26(suppl):26-28.
38. Miller DH. MRI: sensitive and safe in diagnosing multiple sclerosis. MRI Decisions 1988;2:17-24.
39. Canal N, Comi GC, Martinelli V, Filippi M. A comparison of multimodal evoked potentials, nuclear magnetic resonance imaging and CSF profile for the diagnosis of multiple sclerosis. In: Battaglia MA, ed. Multiple sclerosis research. Amsterdam: Elsevier, 1989:105-112.
40. Kidd D, Thorpe JW, Thompson AJ, et al. Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology 1993;43:2632-2637.
41. Isaac C, Li DKB, Genton M, et al. Multiple sclerosis: a serial study using MRI in relapsing patients. Neurology 1988;38:1511-1515.
42. Miller DH, Rudge P, Johnson G, et al. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 1988;111:927-939.
43. Willoughby EW, Grochowski E, Li DKB, et al. Serial magnetic resonance scanning in multiple sclerosis: a second prospective study in relapsing patients. Ann Neurol 1989;25:43-49.
44. Kermode AG, Thompson AJ, Tofts P, et al. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Brain 1990;113:1477-1489.
45. Harris JO, Frank JA, Patronas N, et al. Serial gadolinium- enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann Neurol 1991;29:548-555.
46. Thompson AJ, Kermode AG, Wicks D, et al. Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 1991;29:53-62.
47. Thompson AJ, Miller D, Youl B, et al. Serial gadolinium- enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration. Neurology 1992;42:60-63.
48. Koopmans RA, Li DKB, Zhao GJ, Redekop WK, Paty DW. MRI assessment of cyclosporine therapy of MS in a multicenter trial [abstract]. Neurology 1992;42(suppl 3):210.
49. Paty DW, Li DKB, UBC MS/MRI Study Group, IFNB Multiple Sclerosis Study Group. Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology 1993;43:662-667.
50. Baumhefner RW, Tourtellotte WW, Syndulko K, et al. Quantitative MS plaque assessment with MRI. Its correlation with clinical parameters, EPs, and intra blood-brain barrier. Arch Neurol 1990;47:19-26.
51. McDonald WI, Miller DH, Barnes D. The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol 1992;18:319-334.
52. Youl BD, Turano G, Miller DH, et al. The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits. Brain 1991;114:2437-2450.
53. Broman T, Andersen O, Bergmann I. Clinical studies on multiple sclerosis I: presentation of an incidence material from Gothenburg. Acta Neurol Scand 1981;63:6-33.
54. Lhermitte F, Marteau R, Gazengel J, et al. The frequency of relapse in multiple sclerosis: a study based on 245 cases. J Neurol 1973;205:47-59.